Cerebral white matter degeneration in frontotemporal dementia detected by diffusion-weighted magnetic resonance

Takashi Yoshiura1, Futoshi Mihara, Hiroshi Koga

  • 1Department of Clinical Radiology, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. tyoshiura@syd.odn.ne.jp

Academic Radiology
|October 31, 2006
PubMed
Abstract

Insights

Diffusion-weighted imaging (DWI) revealed white matter microstructural damage in frontotemporal dementia (FTD) patients. These changes in mean diffusivity (MD) suggest FTD impacts brain connectivity.

Area of Science:

  • Neuroimaging
  • Neurology
  • Biomedical Engineering

Background:

  • Frontotemporal dementia (FTD) is a neurodegenerative disorder characterized by progressive brain tissue damage.
  • Systematic investigation of white matter microstructural changes in FTD using diffusion-weighted imaging (DWI) is lacking.

Purpose of the Study:

  • To investigate in vivo white matter microstructural integrity in FTD patients using DWI.
  • To determine if mean diffusivity (MD) abnormalities can be detected in the white matter of FTD patients.

Main Methods:

  • A cohort of 13 FTD patients and 15 age-matched healthy controls were recruited.
  • Diffusion-weighted imaging (DWI) was employed to assess white matter integrity.
  • Mean diffusivity (MD) in 28 white matter regions was evaluated visually and quantitatively relative to the postcentral gyrus.

Main Results:

  • Visual assessment showed significant MD elevation in FTD patients in superior frontal, orbitofrontal, and anterior temporal white matter regions (P < .01).
  • Quantitative analysis confirmed significant MD elevation in bilateral superior frontal, orbitofrontal, and anterior temporal white matter (P < .05 Bonferroni corrected).

Conclusions:

  • The study demonstrates significant white matter mean diffusivity (MD) abnormalities in FTD patients.
  • These findings suggest that white matter changes in FTD may be secondary to cortical damage.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...